The number of people with susceptibility test result for rifampicin in Burkina Faso

Burkina Faso: The number of people with susceptibility test result for rifampicin was 67.26 in 2021. ▲ Rising

Latest (2021)
67.26
Change on year
down 25.4%
World rank
106th
of 146 countries
All-time high
90.19
in 2020
All-time low
22.31
in 2017
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Burkina Faso, 2017–2021

204060801002017201920212017: 22.32018: 29.22019: 53.62020: 90.22021: 67.3

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, the number of people with susceptibility test result for rifampicin in Burkina Faso stood at 67.26.

Compared with earlier readings it is down 25.4% on the previous year and up 201.5% over five years.

That places Burkina Faso 106th out of 146 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Burkina Faso, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in Burkina Faso, 2017 to 2021.
Year Value Change
2017 22.31
2018 29.22 +31.0%
2019 53.59 +83.4%
2020 90.19 +68.3%
2021 67.26 -25.4%

Burkina Faso compared with similar countries

  • Burkina Faso's 67.26 is above the median for low income countries, which is 37.16, 1.8× the median. (13 countries reporting)
  • Burkina Faso's 67.26 is above the median for Sub-Saharan Africa, which is 61.16, 1.1× the median. (32 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 35.04 22.31 53.59 3
2020s 78.72 67.26 90.19 2

Countries ranked near Burkina Faso

  1. 103 Afghanistan 70.58 compare
  2. 104 United Arab Emirates 69.7 compare
  3. 105 Cape Verde 69.01 compare
  4. 107 Kenya 63.13 compare
  5. 108 Japan 62.2 compare
  6. 109 Croatia 60.19 compare

See the full ranking of 148 places →

More health data for Burkina Faso

All data for Burkina Faso →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Burkina Faso?
The number of people with susceptibility test result for rifampicin in Burkina Faso was 67.26 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Burkina Faso?
The highest recorded value was 90.19 in 2020.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Burkina Faso?
The lowest recorded value was 22.31 in 2017.
How does Burkina Faso rank for the number of people with susceptibility test result for rifampicin?
Burkina Faso ranks 106th out of 146 countries with data for 2021.
Where does this Burkina Faso data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Burkina Faso. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/burkina-faso/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/burkina-faso/">The number of people with susceptibility test result for rifampicin in Burkina Faso</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed